$5.74
+0.01(0.20%)
Mkt Cap $20M
$3.35
$10.38
52-Week Range
At a Glance
AI-generatedTAO Synergies reported $299.1K revenue amid a strategic pivot to TAO accumulation, but net loss widened to -$28.7M (-125.1% YoY) due to higher general and administrative expenses and other losses, partially offset by lower R&D spending.
$20M
Market Cap
$283.6K
Revenue
-$36M
Net Income
Employees4
Fundamentals
How The Business Makes Money
Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.
Industry Biotechnology
Activity
What Changed Recently
No significant events in the past 90 days.
Company Profile
CIK0001571934
ISINUS87167T3005
Address1185 Avenue of the Americas, 3rd Floor, New York, 10036, US
SEC EDGAR